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Abstract
Background: Adipocyte hyperplasia is associated with obesity and arises due to adipogenic differentiation of resident 
multipotent stem cells in the vascular stroma of adipose tissue and remote stem cells of other organs. The mechanistic 
characterization of adipocyte differentiation has been researched in murine pre-adipocyte models (i.e. 3T3-L1 and 3T3-
F442A), revealing that growth-arrest pre-adipocytes undergo mitotic clonal expansion and that regulation of the 
differentiation process relies on the sequential expression of three key transcription factors (C/EBP?, C/EBP? and PPAR?). 
However, the mechanisms underlying adipocyte differentiation from multipotent stem cells, particularly human 
mesenchymal stem cells (hBMSCs), remain poorly understood. This study investigated cell cycle regulation and the 
roles of C/EBP?, C/EBP? and PPAR? during adipocyte differentiation from hBMSCs.
Results: Utilising a BrdU incorporation assay and manual cell counting it was demonstrated that induction of 
adipocyte differentiation in culture resulted in 3T3-L1 pre-adipocytes but not hBMSCs undergoing mitotic clonal 
expansion. Knock-down and over-expression assays revealed that C/EBP?, C/EBP? and PPAR? were required for 
adipocyte differentiation from hBMSCs. C/EBP? and C/EBP? individually induced adipocyte differentiation in the 
presence of inducers; PPAR? alone initiated adipocyte differentiation but the cells failed to differentiate fully. Therefore, 
the roles of these transcription factors during human adipocyte differentiation are different from their respective roles 
in mouse.
Conclusions: The characteristics of hBMSCs during adipogenic differentiation are different from those of murine cells. 
These findings could be important in elucidating the mechanisms underlying human obesity further.
Background
Increased adipose tissue mass associated with obesity is 
due to the increased number and size of adipocytes [1,2]. 
Adipocyte differentiation from mesenchymal stem cells 
plays an important role in the hyperplasia of adult adi-
pose tissue. A population of cells resident in the vascular 
stroma of adipose tissue can differentiate into adipocytes 
in vitro and in vivo [3]. Recent studies indicate that peri-
cytes in blood vessel walls have adipogenic potential, 
express mesenchymal stem cell (MSC) markers and are 
multipotent [4]. In addition to resident stem cells, non-
resident stem cells can serve as a source of adipocyte pre-
cursors; bone marrow MSCs can be recruited to adipose 
tissue and generate new adipocytes in response to treat-
ment with thiazolidinediones (TZDs) or high fat stimula-
tion [5].
The characteristics and molecular mechanism underlying 
adipocyte differentiation have been extensively investi-
gated in the murine pre-adipocyte cell lines 3T3-L1 and 
3T3-F442A [6,7]. Growth-arrested pre-adipocytes have 
been shown to re-enter the cell cycle synchronously and 
undergo mitotic clonal expansion in response to MDI (M: 
methyl-isobutyl-xanthine, D: dexamethasone, I: insulin) 
treatment, before exiting the cell cycle and terminally dif-
ferentiating [8]. The transcription factors C/EBP? 
(CCAAT/enhancer binding protein ?), C/EBP? (CCAAT/
enhancer binding protein ?) and PPAR? (peroxisome pro-
liferator-activated receptor ?) act sequentially during 
3T3-L1 pre-adipocyte differentiation [9]. C/EBP? is 
induced immediately after exposure to the differentiation 
cocktail, resulting in phosphorylation and activation 
[10,11], and it transactivates the expression of C/EBP? 
and PPAR? [12]. C/EBP? and PPAR?, together or in isola-
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tion, can initiate differentiation without inducers [13-15]. 
C/EPB? is believed to be relevant to the acquisition of 
insulin sensitivity [16].
MSCs have been isolated and induced to differentiate 
into adipocytes in a variety of organs [17-22]. However, 
the differentiation procedure and the roles of adipose-
related genes in that procedure have not been character-
ized completely owing to the heterogeneity, low prolifera-
tion ability and ineffective ectopic gene transfection of 
hBMSCs [23,24]. Human primary cells are of great inter-
est because of their biological and therapeutic potential, 
therefore this study extends the research carried out in 
murine 3T3-L1 cells to hBMSCs from bone marrow.
Results
Isolation and adipogenic differentiation of hBMSCs
Isolated hBMSCs presented with a typical spindle-shape 
phenotype (Figure 1A), and cells from passages 3-5 were 
used for the following studies. In addition to fetal bovine 
serum (FBS), methyl-isobutyl-xanthine, dexamethasone 
and insulin (MDI) used to induce 3T3-L1 adipocyte dif-
ferentiation, indomethacin (Indo), a PPAR? agonist [25], 
was added to the culture medium (MDI+Indo) to induce 
adipocyte differentiation from hBMSCs [26]. Each cycle 
of MDI+Indo threatment only induced a portion of hBM-
SCs to go into adipocyte differentiation, and about 60%-
70% hBMSCs differentiated into adipocytes after three 
cycles of MDI+Indo induction as indicated by oil red O 
staining (Figure 1B). Consistent with the morphological 
changes, the expression of the adipose-specific gene 
FABP4 (422/aP2 in mouse) was significantly induced 
throughout differentiation as determined by Western 
Blotting (Figure 1C).
Cell cycle alteration during adipocyte differentiation from 
hBMSCs
HBMSCs proliferated slowly, approximately <10% of cells 
were actively dividing revealed by DNA content with flow 
cytometry (Fig.2A). About 90% of the cells in G0/G1 
phase were at the dividing stage, and approximately 95% 
at the post-confluence stage (Figure 2B). Contact inhibi-
tion was not apparent, as observed that if plated at a den-
sity of 5000 cells/cm2 and cultured for five weeks, the cells 
locally grew into multi-layers (Figure 2C).
Cell cycle regulation is an important event in adipocyte 
differentiation of mouse 3T3-L1 pre-adipocytes [8,11]. 
Growth-arrested 3T3-L1 pre-adipocytes synchronously 
re-enter the cell cycle upon MDI induction and undergo 
two rounds of division before expression of adipocyte-
specific genes and presenting with the mature adipocyte 
phenotype. In order to investigate whether hBMSCs 
undergo division during adipocyte differentiation, the 
number of cells was counted (Figure 3B). The cell number 
marginally increased (1.24 fold) in the control group after 
a 21-day culture (Figure 3A). There was an increase in the 
cell number (1.17 fold) in differentiation cultures but less 
than that in the control, and as the number of differenti-
ated cells increased after repeated inductions, the rate of 
increase of cell numbers declined. These results suggest 
that the proliferation of undifferentiated cells contributed 
to the increase in cell numbers.
BrdU incorporation assays were performed to investigate 
whether DNA synthesis occurs during adipocyte differ-
entiation from hBMSCs. We found that differentiated 
hBMSCs were BrdU negative, while differentiated 3T3-
L1 cells were BrdU positive (Figure 3C). Confocal micros-
copy verified the positional relationship between nuclei 
(as indicated by BrdU incorporation into DNA) and cells 
with lipid droplets in the cytoplasm (Figure 3D, 3E). 
These results demonstrate that hBMSCs did not undergo 
mitotic clonal expansion during adipogenic differentia-
tion under culture conditions.
Role of C/EBP? in adipocyte differentiation of hBMSCs
In order to define the role of C/EBP? in adipocyte differ-
entiation of hBMSCs, the expression profile was deter-
mined. Expression of C/EBP? in hBMSCs could be 
detected at the start of induction by real-time PCR; the 
expression level did not change significantly during the 
early stages of induction (Figure 4A) but declined after 14 
days when most of the cells had differentiated. Regarding 
the expression difference between 3T3-L1 and hBMSCs, 
C/EBP? expression was knocked down by siRNA to 
determine whether C/EBP? is essential during adipocyte 
differentiation from hBMSCs; and knocked-down 
expression of C/EBP? was confirmed by real-time PCR 
(Figure 4C). HBMSCs failed to differentiate into adipo-
cytes after C/EBP? was knocked down (Figure 4B).
C/EBP? was over-expressed in hBMSCs using an aden-
ovirus expression system (Figure 4D) to investigate its 
function during differentiation. Control cells expressing 
Lac Z didn't differentiate, while expression of exogenous 
C/EBP? alone induced adipogenesis (Figure 4E), and 
some cells presented with small intracellular fat droplets 
that could not be adequately stained using oil red O. 
However, FABP4 expression was detected by western 
blotting (Figure 4F) and was significantly up-regulated by 
the addition of inducers, the highest levels of expression 
being evident when indomethacin (PPAR? agonist) was 
included (Figure 4E, 4F).
Role of C/EBP? in adipocyte differentiation from hBMSCs
Expression of C/EBP? increased one day after induction, 
reached a maximum level after three days and decreased 
by day 14 when adipocyte differentiation had occurred 
(Figure 5A). As Figure 5B demonstrates, knocked-down 
expression of C/EBP? (Figure 5C) with an adenovirus car-
rying C/EBP? shRNA impaired the differentiation of Qian et al. BMC Developmental Biology 2010, 10:47
http://www.biomedcentral.com/1471-213X/10/47
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Figure 1 Isolation and adipogenic differentiation of hBMSCs. (A) The morphology of adherent hBMSCs three and 12 days after plating (magnifi-
cation 100×). (B) HBMSCs of P5 were cultured for one week after confluence and induced to differentiate with MDI+Indo (M: methyl-isobutyl-xanthine; 
D: dexamethasone; I: insulin; Indo: indomethacin) treatment for one, two or three cycles (1 cycle of treatment: MDI+Indo for three days followed by 
insulin for one day). The accumulation of cytoplasmic triglyceride was detected by Oil Red O staining on day 21 and visualized under a microscope 
(magnification 100×). (C) FABP4 expression was examined by Western Blotting at the indicated days after differentiation with repeated MDI+Indo 
treatment (three times).Qian et al. BMC Developmental Biology 2010, 10:47
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Figure 2 Growth characteristic of hBMSCs. (A) Confluent hBMSCs were trypsinized, fixed and stained with PI. DNA content in cells was examined 
by flow cytometry. (B) Pre-confluent (density ~80%) and post-confluent (one week after cells reach confluence) hBMSCs from three separate experi-
ments at different cell cycle stages revealed by flow cytometry were quantified. (C) Morphology of hBMSCs at different densities (plated at 5000/cm2 
and cultured for one day, one week and five weeks).Qian et al. BMC Developmental Biology 2010, 10:47
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hBMSCs, while over-expression of C/EBP? (Figure 5D) in 
hBMSCs did not induce adipocyte differentiation. How-
ever, C/EBP? together with indomethacin or MDI 
induced a small proportion of the cells to differentiate, 
and when both indomethatin and MDI were added with 
C/EBP?, the number of differentiated adipocytes 
increased as demonstrated by oil red O staining (Figure 
5E) and Western Blotting of FABP4 expression (Figure 
5F).
Role of PPAR? in adipocyte differentiation from hBMSCs
The induction of PPAR? expression was similar to that of 
C/EBP? (Figure 6A, Figure 5A). Knock-down of PPAR? 
expression in hBMSCs (Figure 6C) prevented adipocyte 
differentiation (Figure 6B), while over-expression of 
PPAR? (Figure 6D) induced adipogenic differentiation 
(Figure 6E), resulting in fat droplet accumulation in the 
vast majority of cells. Addition of an exogenous PPAR? 
agonist (indomethacin) enhanced the function of PPAR? 
as determined by oil red O staining (Figure 6E) and 
FABP4 expression (Figure 6F). Fat droplets appeared 
three days after adenoviral infection but were smaller 
than those induced by MDI+Indo (Figure 6G). The 
expression ratio of GLUT4 to FABP4 in adipocytes 
induced by PPAR? over-expression was lower than that in 
cells induced by three cycles of MDI+Indo (Figure 6H).
Figure 3 Cell cycle progression during adipogenic differentiation of hBMSCs. (A) Post-confluence hBMSCs with or without induction (MDI+Indo 
treatment for one, two or three cycles) were counted and plotted on day 0 and day 21. (B) Cells with parallel treatment in (A) were also stained with 
oil red O on day 21 and photographed (magnification 100×). (C) 10 ?g/ml BrdU was added to 3T3-L1 cells at 18 h after MDI treatment for 30 h, and 
added to hBMSC at 24 h for 48 h. BrdU incorporation was detected by immunocytochemistry and photographed with both a halogen and mercury 
lamp switched on (magnification 200×). In 3T3-L1 cells (D) and hBMSCs (E) with or without induction (control), incorporated BrdU (FITC) and fat lipids 
(TRITC) were shown by confocal microscopy.Qian et al. BMC Developmental Biology 2010, 10:47
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Discussion
HBMSCs are more difficult to handle than mouse stem 
cell lines but their importance and therapeutic potential 
necessitate their use in research of the type outlined 
herein. The previous studies are focused on the mouse 
stem cell lines but the regulation of them could be differ-
ent in some aspects, and results of murine cells would be 
less convincing in interpreting the onset of human dis-
ease. On the other hand, adipocytes differentiated from 
HBMSCs would be of better immuno-compatibility in 
autograft for plastic purpose. So, in this study, a compre-
hensive analysis of adipocyte differentiation from multi-
potent human stem cells was carried out.
HBMSCs were isolated from bone marrow and induced 
to differentiate into adipocytes under culture conditions. 
The PPAR? agonist, indomethacin, was added as well as 
the conventional inducers used in adipocyte differentia-
tion protocols for murine pre-adipocytes. HBMSCs 
behaved differently from 3T3-L1 pre-adipocytes, with 
only a small number of cells differentiating into adipo-
cytes after one cycle of treatment; approximately 
60%~70% of hBMSCs differentiated into adipocytes after 
three cycles of treatment (Figure 1B). A long G0 phase 
and a lack of contact inhibition (Figure 2C) meant that 
hBMSCs did not synchronize at the time when differenti-
ation was initiated (Figure 2B). Growth arrest is a prereq-
uisite for adipocyte differentiation [27], so it was 
concluded that only a minority of hBMSCs were growth 
arrested when differentiation was induced.
MCE (mitotic clonal expansion) is an essential event 
associated with adipocyte differentiation from mouse 
pre-adipocyte cell lines [8,11]. However, it is not known 
whether MCE is required for adipocyte differentiation 
from all cell types. We have previously demonstrated that 
Figure 4 C/EBP? was required for and stimulated adipocyte differentiation from hBMSCs. (A) Relative expression levels of C/EBP? were deter-
mined at the indicated days by real-time PCR. (B) Adipogeic differentiation revealed by oil red O staining with C/EBP? knock-down by SiRNA. (C) Ex-
pression levels of C/EBP? were determined by real-time PCR (n = 3, *P < 0.05). (D) Over-expression of C/EBP? in hBMSCs with adenoviral infection (Lac 
Z as control) was confirmed by Western Blotting. (E) HBMSCs were cultured to confluence and infected with adenovirus at MOI 10 followed by various 
combination of hormone treatment 4 h later for three days. Cells were stained with oil red O on day eight (magnification 100×). (F) The expression of 
the adipocyte marker (FABP4) was detected on day four by Western Blotting.Qian et al. BMC Developmental Biology 2010, 10:47
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committed C3H10T1/2 cells treated with BMP4 divide 
when induced to differentiate [28], and primary cultures 
of mouse embryonic fibroblasts (MEF) undergo MCE 
when differentiating into adipocytes [29]. In this study, 
hBMSCs from bone marrow did not undergo division 
during differentiation (Figure 3), which is in agreement 
with other reports showing that adipose precursor cells 
prepared from human adipose tissue (hADSCs) did not 
divide during differentiation under culture conditions 
[30]. The authors argued that hADSCs had completed 
division before being isolated; however, hADSCs are mul-
tipotent and can differentiate into other cell lineages 
including adipocytes ex vivo [31,32]. HADSCs could 
behave similarly to hBMSCs from bone marrow under 
culture conditions and remain uncommitted. The diver-
sity of cell cycle alterations during adipocyte differentia-
tion could be species-specific.
Murine proteins and comparable human proteins can 
function differently in the same context. In this study, C/
EBP? expression in hBMSCs did not alter significantly 
during the early stages of induction whereas expression 
was up-regulated immediately following induction and 
declined after two days in 3T3-L1 pre-adipocytes [33]. 
The decline of C/EBP? at 14 day might result from most 
of cells being terminal differentiated. However, C/EBP? 
was required for adipocyte differentiation in hBMSCs as 
its knock-down expression impaired differentiation (Fig-
ure 4B, 4C). C/EBP? has important roles in mitosis and 
terminal adipocyte differentiation [34,35], but mitosis did 
not occur during differentiation of hBMSCs (Figure 3) 
and that could possibly explain the lack of differential 
expression of C/EBP? upon induction. It is likely that the 
role of C/EBP? during adipocyte differentiation from 
hBMSCs relates to its modification and not its expression 
Figure 5 C/EBP? was required for and stimulated adipocyte differentiation from hBMSCs. (A) Relative expression levels of C/EBP? were deter-
mined at the indicated days by real-time PCR. (B) Adipocyte differentiation revealed by oil red O staining with C/EBP? knock-down by adenovirus ex-
pressing shRNA. (C) C/EBP? knock-down was confirmed by real-time PCR (n = 3, *P < 0.05). (D) C/EBP? over-expression in hBMSCs using adenovirus 
(Lac Z as control) was shown by Western Blotting. (E) HBMSCs were cultured to confluence and infected with adenovirus at MOI 10 followed by various 
combinations of hormone treatment 4 h later for three days. Cells were stained with oil red O on day eight (magnification 100×). (F) The expression 
of the adipocyte marker (FABP4) was detected on day four by Western Blotting.Qian et al. BMC Developmental Biology 2010, 10:47
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levels, although the importance of C/EBP? phosphoryla-
tion requires further investigation.
C/EBP? or C/EBP? is sufficient to induce 3T3-L1 pre-adi-
pocytes to differentiate into mature adipocytes without 
using inducers [36,37]. Over-expression of C/EBP? alone 
stimulated differentiation of hBMSCs, as evidenced by 
FABP4 expression (Figure 4E, 4F). C/EBP? was less effec-
tive than C/EBP? as expression of C/EBP? alone did not 
stimulate differentiation (Figure 5E, 5F). C/EBP? and C/
EBP? individually enhanced adipocyte differentiation of 
hBMSCs dependent on exogenous hormone agent treat-
ment, particularly in the presence of a PPAR? activator 
(Figure 4E, 4F, 5E, 5F). HBMSCs may lack endogenous 
PPAR? ligands; however, this cannot be determined at 
this time because the results concerning the study of nat-
ural PPAR? ligands are indecisive [38].
PPAR? plays pivotal roles in adipocyte differentiation as it 
induces adipogenesis in cultured mouse fibroblasts [14]. 
With the use of high affinity, selective PPAR? agonists, 
PPAR? activation stimulates 3T3-F442A cells to develop 
into mature fat cells with a phenotype that includes mor-
phological changes, lipid accumulation, and the acquisi-
tion of insulin sensitivity [39]. In addition, ectopic 
expression of PPAR? in hBMSCs initiates adipocyte dif-
ferentiation. However, these cells were immature adipo-
cytes, as demonstrated by morphological observations 
Figure 6 PPAR? was sufficient to initiate adipocyte differentiation from hBMSCs, but could not induce fully developed adipocytes. (A) Rel-
ative expression levels of PPAR? were determined at the indicated days by real-time PCR. (B) Adipogeic differentiation revealed by oil red O staining 
with PPAR? knock-down by adenovirus expressing shRNA. (C) PPAR? knock-down was verified by real-time PCR (n = 3, *P < 0.05). (D) PPAR? over-ex-
pression in hMBSCs with adenovirus (Lac Z as control) was shown by Western Blotting. (E) HBMSCs were cultured to confluence and infected with 
adenovirus at MOI 10 alone or in combination with indomethacin. Lipid droplets indicated by oil red O staining on day 14 (magnification 100×). (F) 
The expression of adipocyte marker FABP4 was detected on day six by Western Blotting. (G) Morphology of lipid droplets induced by PPAR? expression 
and hormone treatment (magnification 200×). (H) GLUT4 expression normalized by FABP4 was quantified by real-time PCR in cells treated with PPAR? 
adenovirus or hormone (n = 3, *P < 0.05).Qian et al. BMC Developmental Biology 2010, 10:47
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and the expression of some adipocyte-specific genes (Fig-
ure 6G, 6H). In humans, PPAR? functions to regulate a 
part of genes required for adipocyte maturation, as dem-
onstrated by its ability to induce FABP4 but not GLUT4 
expression (Figure 6H). In addition, PPAR? could play a 
role in cytoskeletal alterations associated with the mor-
phological changes during differentiation, as the cells 
rounded up when PPAR? was over-expressed and elon-
gated when expression of PPAR? was knocked down.
Conclusions
This study demonstrates that the characteristics of hBM-
SCs during adipogenic differentiation are different from 
those of mouse cells. HBMSCs do not undergo mitotic 
clonal expansion during adipocyte differentiation. C/
EBP?, C/EBP?, and PPAR? are all required but not suffi-
cient for adipocyte differentiation from hBMSCs. The 
ability of the transcription factors to stimulate adipocyte 
differentiation differed between human and murine cells. 
Further studies concerning on how C/EBP?, C/EBP? and 
PPAR? regulating human adipocyte differentiation could 
help to elucidate the molecular mechanism of adipocyte 
differentiation from human stem cells, help to elucidate 
the mechanisms underlying human obesity and identify 
therapeutic targets.
Methods
Donor information
Bone marrow was obtained from the iliums of patients 
undergoing iliac crest bone grafts following informed 
consent. Five samples were obtained from male patients 
between the ages of 25 and 55 years who did not suffer 
from obesity and/or diabetes. The sample collection pro-
cedure and related research work was approved by the 
ethics committee of Institutes of Biomedical Sciences, 
Fudan University. Results were reproducible between 
donors, and the data presented in the results section were 
from a 32-year-old male donor.
Isolation and adipogenic differentiation of hBMSCs
HBMSCs were isolated by density gradient centrifugation 
with Ficoll-Paque (GE Healthcare) and plastic adherence 
and grown in DMEM (low glucose, Invitrogen) contain-
ing 10% fetal bovine serum and 1% antibiotics; cells from 
passages 3-5 were used experimentally. A published pro-
tocol was followed to induce adipogenic differentiation of 
hBMSCs [26]. HBMSCs were cultured at a density of 
5000~6000 cells/cm2. After reaching confluence, hBM-
SCs were cultured for one more week and induced in adi-
pogenic medium containing 0.5 mM isobutyl-
methylxanthine (Sigma-Aldrich), 1 ?M dexamethasone 
(Sigma-Aldrich), 10 ?M insulin (Roche), 100 ?M 
indomethacin (Sigma-Aldrich) for three days and main-
tained in medium with 10 ?M insulin for one day. The 
treatment was repeated two or three times, after which 
the cells were maintained in DMEM with 10 ?M insulin 
until day 21 and subjected to oil red O staining to detect 
cytoplasmic triglyceride.
Oil red O staining
Cells were washed three times with PBS and then fixed 
for 2 min with 3.7% formaldehyde. Oil red O (0.5% in iso-
propanol) was diluted with water (3:2) filtered through a 
0.45 ?m filter and incubated with the fixed cells for 1 h at 
room temperature. Cells were washed with water and the 
stained fat droplets in the cells were visualized by light 
microscopy and photographed. The percentage of differ-
entiated cells was determined by counting cells based on 
oil red staining in the lipid vacuoles and 4',6'-diamidino-
2-phenylindole staining of DNA.
Western blotting
At various time points cells were washed with cold PBS 
(pH 7.4) and lysed with lysis buffer (2% SDS, 60 mM Tris-
Cl, pH 6.8). The lysates were heated to 100°C for 10 min 
and clarified by centrifugation; equal amounts of protein 
were separated by SDS-PAGE. Proteins were transferred 
to poly(vinylidene difluoride) membranes and immunob-
lotted with antibodies to FABP4(422/aP2), C/EBP?, C/
EBP?, and PPAR? [antibodies to 422/aP2, C/EBP? and C/
EBP? were provided by Dr. M Daniel Lane (Johns Hop-
kins University School of Medicine, Baltimore) and the 
antibody to PPAR? was purchased from Cell Signalling 
Technology ].
Cell cycle analysis by propidium iodide staining and flow 
cytometry
Cells were trypsinized, washed with PBS and fixed with 
2% (wt/vol) paraformaldehyde in PBS. They were treated 
with 0.5 mg/ml RNase A for 1 h at room temperature and 
incubated with 0.1 mg/ml propidium iodide (Sigma) for 
45 min at 37°C. DNA content was determined by flow 
cytometry (Bio-Rad).
BrdU labelling and immunofluorescence microscopy
BrdU labeling of hBMSCs and 3T3-L1 cells (kindly pro-
vided by Dr. M Daniel Lane, Johns Hopkins University 
School of Medicine, Baltimore) was performed following 
the procedure published by Tang [8] with modifications. 
Cells were plated on to cover-slips and maintained in 
DMEM containing 10% FBS for several days after conflu-
ence and induced to differentiate. Regarding the growth 
kinetics differennce (hBMSCs have a longer G0/G1 phase 
than 3T3-L1, the entry of hBMSCs into S phase is ~20h at 
passage 3 [40]), BrdU for 3T3-L1, BrdU (10 ?g/ml) was 
added at 18 h after induction (during S phase[8]) until 48 
h and then shifted to maintain medium (with insulin 
only); for hBMSCs, BrdU was added at 24 h until 72 h. 
After differentiation, the cover-slips were fixed in 70% Qian et al. BMC Developmental Biology 2010, 10:47
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ethanol for 30 min followed by 100% methanol for 10 min 
at room temperature. The fixed cells were treated for 30 
min with 1.5 M HCl, blocked with 0.5% Tween 20 in PBS 
with 10% FBS for 5 min, incubated with anti-BrdU (1:100, 
Sigma) or anti-perilipin (1:50, Santa Cruz) primary anti-
bodies in the same buffer overnight, and incubated with 
FITC/TRITC-conjugated secondary antibodies for 1-2 h. 
Nuclei were counterstained with 4˜,6-diamidino-2-phe-
nylindole (DAPI). Images were taken on a confocal 
microscope.
Adenoviral expression vectors and infection
The adenoviral expression vectors pAd/CMV/V5-DEST 
(Invitrogen) encoding human C/EBP?, C/EBP?, PPAR? 
and Lac Z (control) were constructed according to the 
manufacturer's protocols. shRNAs for C/EBP?, PPAR? 
and Lac Z were cloned into pBlock-it (Invitrogen). The 
sequences of the shRNAs were as follows: C/EBP?, CAC-
CAGGAGGATGAAGCCAAGCAGCTCGAAAGCT-
GCTTGGCTTCATCCTCCT. PPAR?, 
CACCGGGTGAAACTCTGGGAGATTCCGAA-
GAATCTCCCAGAGTTTCACCC. Confluent hBMSCs 
were infected with the adenovirus at MOI (multiplicity of 
infection) of 10 for 4 h; the expression of human C/EBP?, 
C/EBP?, PPAR? was assessed by real-time PCR at 24 h or 
by immunoblotting with antibodies against human C/
EBP?, C/EBP?, PPAR? and FLAG at 48 h. For adipocyte 
differentiation, various combinations of inducers were 
added to the infected cells for three days. Oil red O stain-
ing was used to demonstrate fat lipid accumulation on 
day eight and western blotting was used to demonstrate 
FABP4 (422/aP2 in mouse) expression on day four.
RNAi of C/EBP? with siRNA
SiRNA oligonucleotides specific for C/EBP? mRNA (5'-
CCCUGCGGAACUUGUUCAAGCAGCU-3') were syn-
thesized by Invitrogen. The silencing effect was verified 
by real-time PCR for C/EBP? expression. HBMSCs in 60 
mm dishes at 60-70% confluence were transfected with 
Negative and C/EBP? siRNA oligonucleotides by using 
Lipofectamine RNAiMAX (Invitrogen). After 24 h the 
cells were trypsynized and plated into 35 mm dishes in 
order to reach confluence immediately. After a further 24 
h they were induced to differentiate by three cycles of 
treatment, and subjected to oil red O staining at day 14.
Real-time quantitative PCR
Real-time quantitative PCRs were performed with 2× 
PCR Master Mix (Power SYBR® Green, ABI) on a Bio-Rad 
Q5 instrument (Bio-Rad). The threshold cycles (Ct) for 
the target genes and the 18S rRNA control signals were 
determined in triplicate experiments, and the relative 
RNA quantity was calculated using the comparative Ct 
method. Primers were as follows:
18S rRNA: Forward 5'-CGGCTACCACATCCAAG-
GAA-3', Reverse 5'-GCTGGAATTACCGCGGCT-3'.
C/EBP?: Forward 5'-GCAAGAGCCGCGACAAG-3', 
Reverse 5'-GGCTCGGGCAGCTGCTT-3'.
C/EBP?: Forward 5'-AAGAAGTCGGTGGACAAGAA-
CAG-3', Reverse 5'-TGCGCACCGCGATGT-3'.
PPAR?: Forward 5'-GATACACTGTCTGCAAACATAT-
CACAA-3', Reverse 5'-CCACGGAGCTGATCCCAA-3'.
FABP4: Forward 5'-GCTTTGCCACCAGGAAAGTG-3', 
Reverse 5'-ATGGACGCATTCCACCACCA-3'.
GLUT4: Forward 5'-GCCGGACGTTTGACCAGAT-3', 
Reverse 5'-TGGGTTTCACCTCCTGCTCTA-3'.
Statistics
Data were expressed as the mean ± SD of three separate 
experiments performed in duplicate. Student's t-test was 
used for comparison of results in Figure 4C, Figure 5C 
and Figure 6C &6H.
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